idebenone has been researched along with Dementia in 4 studies
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Noben (idebenone) was administered in dosage 120 mg during 6 months to 35 patients, aged from 60 to 86 years, with dementia, Alzheimer's type and mixed type, and with memory disturbances which did not reach the level of dementia." | 9.13 | [Noben (idebenone) in the treatment of dementia and memory impairment without dementia]. ( Meleshkov, MN; Voronkova, KV, 2008) |
| "Noben (idebenone) at a dose of 120 mg per day for six months was used in the treatment of 35 patients aged 60-86 years with Alzheimer's-type dementia, mixed dementia, and memory impairments not reaching the stage of dementia." | 7.75 | Use of Noben (idebenone) in the treatment of dementia and memory impairments without dementia. ( Meleshkov, MN; Voronkova, KV, 2009) |
| "Noben (idebenone) was administered in dosage 120 mg during 6 months to 35 patients, aged from 60 to 86 years, with dementia, Alzheimer's type and mixed type, and with memory disturbances which did not reach the level of dementia." | 5.13 | [Noben (idebenone) in the treatment of dementia and memory impairment without dementia]. ( Meleshkov, MN; Voronkova, KV, 2008) |
| "Noben (idebenone) at a dose of 120 mg per day for six months was used in the treatment of 35 patients aged 60-86 years with Alzheimer's-type dementia, mixed dementia, and memory impairments not reaching the stage of dementia." | 3.75 | Use of Noben (idebenone) in the treatment of dementia and memory impairments without dementia. ( Meleshkov, MN; Voronkova, KV, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Voronkova, KV | 2 |
| Meleshkov, MN | 2 |
| Otomo, E | 1 |
| Kawakami, M | 1 |
| Itoh, T | 1 |
1 review available for idebenone and Dementia
| Article | Year |
|---|---|
[Cerebral circulatory improvers and metabolic activators].
Topics: Aged; Antidepressive Agents; Benzoquinones; Brain; Cerebrovascular Circulation; Cerebrovascular Diso | 1994 |
1 trial available for idebenone and Dementia
| Article | Year |
|---|---|
[Noben (idebenone) in the treatment of dementia and memory impairment without dementia].
Topics: Aged; Aged, 80 and over; Antioxidants; Attention; Cognition; Cognition Disorders; Dementia; Dose-Res | 2008 |
2 other studies available for idebenone and Dementia
| Article | Year |
|---|---|
Use of Noben (idebenone) in the treatment of dementia and memory impairments without dementia.
Topics: Aged; Aged, 80 and over; Antioxidants; Attention; Cognition; Cognition Disorders; Dementia; Dose-Res | 2009 |
[Effects of idebenone on monoamine metabolites in the cerebrospinal fluid of patients with cerebrovascular dementia].
Topics: Aged; Benzoquinones; Biogenic Amines; Cerebrovascular Disorders; Chromatography, High Pressure Liqui | 1986 |